Tesarova P - Search Results

1

Breast cancer in the elderly-Should it be treated differently?

Tesarova P. Tesarova P. Rep Pract Oncol Radiother. 2012 Jul 15;18(1):26-33. doi: 10.1016/j.rpor.2012.05.005. Rep Pract Oncol Radiother. 2012. PMID: 24381744 Free PMC article. Review.

2

Specific Aspects of Breast Cancer Therapy of Elderly Women.

Tesarova P. Tesarova P. Biomed Res Int. 2016;2016:1381695. doi: 10.1155/2016/1381695. Epub 2016 Oct 11. Biomed Res Int. 2016. PMID: 27807536 Free PMC article. Review.

3

Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.

Tesarová P, Kalousová M, Jáchymová M, Mestek O, Petruzelka L, Zima T. Tesarová P, et al. Cancer Invest. 2007 Dec;25(8):720-5. doi: 10.1080/07357900701560521. Cancer Invest. 2007. PMID: 18058469

4

Glyoxalase I Glu111Ala polymorphism in patients with breast cancer.

Germanová A, Germanová A, Tesarová P, Jáchymová M, Zvára K, Zima T, Kalousová M. Germanová A, et al. Among authors: tesarova p. Cancer Invest. 2009 Jul;27(6):655-60. doi: 10.1080/07357900802350822. Cancer Invest. 2009. PMID: 19452310

5

Disseminated and circulating tumour cells and their role in breast cancer.

Čabiňaková M, Tesařová P. Čabiňaková M, et al. Among authors: tesarova p. Folia Biol (Praha). 2012;58(3):87-97. Folia Biol (Praha). 2012. PMID: 22849858 Free article. Review.

6

Circulating tumor cells in patients with breast cancer: monitoring chemotherapy success.

Ušiaková Z, Mikulová V, Pintérová D, Brychta M, Valchář J, Kubecová M, Tesařová P, Bobek V, Kološtová K. Ušiaková Z, et al. Among authors: tesarova p. In Vivo. 2014 Jul-Aug;28(4):605-14. In Vivo. 2014. PMID: 24982230

7

Contribution of ABCB1 and CYP2D6 genotypes to the outcome of tamoxifen adjuvant treatment in premenopausal women with breast cancer.

Argalácsová S, Slanař O, Vítek P, Tesařová P, Bakhouche H, DraŽďáková M, Bartošová O, Zima T, PertuŽelka L. Argalácsová S, et al. Among authors: tesarova p. Physiol Res. 2015;64(Suppl 4):S539-47. doi: 10.33549/physiolres.933234. Physiol Res. 2015. PMID: 26681084 Free article.

8

Polymorphisms of the receptor for advanced glycation end products and glyoxalase I and long-term outcome in patients with breast cancer.

Tesarova P, Zima T, Kubena AA, Kalousova M. Tesarova P, et al. Tumour Biol. 2017 Jul;39(7):1010428317702902. doi: 10.1177/1010428317702902. Tumour Biol. 2017. PMID: 28695773 Free article.

9

Molecular pathological predictive diagnostics in a patient with non-small cell lung cancer treated with crizotinib therapy: A case report.

Stanek L, Springer D, Konopasek B, Vocka M, Tesarova P, Syrucek M, Petruzelka L, Vicha A, Musil Z. Stanek L, et al. Among authors: tesarova p. Oncol Lett. 2017 Dec;14(6):7545-7548. doi: 10.3892/ol.2017.7167. Epub 2017 Oct 11. Oncol Lett. 2017. PMID: 29344200 Free PMC article.

10

Association of triple positivity with prognostic parameters and overall survival in a population-based study of 6,122 HER2-positive breast cancer patients: analysis of real-world clinical practice based on a research database.

Kolarova I, Vanasek J, Dolezel M, Stuk J, Hlavka A, Dusek L, Melichar B, Büchler T, Ryska A, Prausova J, Petrakova K, Tesarova P, Petera J, Vosmik M, Horackova K, Jarkovsky J. Kolarova I, et al. Among authors: tesarova p. Neoplasma. 2020 Nov;67(6):1373-1383. doi: 10.4149/neo_2020_191023N1080. Epub 2020 Jul 1. Neoplasma. 2020. PMID: 32614235

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page